Our case studies and publications provide an inside look at how our products and solutions have been used to meet diverse hospital needs.
Healthcare Associated Infections (HAIs) are an enormous problem for patients and acute healthcare facilities. To reduce HAIs, many hospitals are employing innovative technology to supplement manual cleaning practices in their quest to combat pathogens in their facility. Whole room fogging technology and UVC light technology are two technologies being used in today’s healthcare environments.
Healthcare Associated Infections (HAIs) are a huge problem for patients and acute healthcare facilities. The impact of HAIs is detrimental to patient outcomes and increases the cost of provider care. In hospitals alone, the Centers for Disease Control and Prevention (CDC) estimate HAIs account for 1.7 million infections and more than 98,000 deaths each year.1 Approximately $45 billion in direct hospital costs are associated annually for the treatment of HAIs.2 Hospital environment, health care staff, visitors and patient medical conditions are contributing factors to the development of HAIs.
Nevoa® is a healthcare innovation company dedicated to reducing the impact of hospital acquired infections (HAIs) through better disinfection technology.
Nevoa saw a need to reduce human error and cross-contamination common to manual disinfection protocols. Nevoa developed a system consisting of a proprietary hypochlorous acid (HOCl) solution called Nevoa Microburst SolutionTM and an automated robot called NimbusTM. The patented Nimbus device atomizes (fogs) the disinfectant for whole-room disinfection including 100% of a room’s surfaces as well as room air. This system is the only US Environmental Protection Agency (EPA) registered disinfectant approved for fogging HOCl in healthcare environments. Rigorous testing has been conducted through independent laboratories to provide the necessary validation studies for EPA registration. Additional studies have also been conducted to demonstrate efficacy against several specific pathogens of interest.
Assess the effectiveness of a whole-room, no-touch disinfection system in conjunction with manual cleaning protocols in reducing bacterial contamination on healthcare surfaces.
Healthcare Associated Infections (HAIs) are an enormous problem in hospitals that contribute to the morbidity and mortality of patients. Oncology and similar high-risk patients are extremely susceptible to the development of HAIs because of their compromised immune systems.
In this retrospective cohort study, we used a real-time location system to track the movement of hospital beds in 2 academic hospitals to determine whether residing in a hospital bed that previously held an occupant with Clostridioides difficile increases the risk of hospital-onset C. difficile infection (HO-CDI).
The first 1-minute, 2-step, disposable surgically-proven nasal treatment.
Endogenous bacteria are known to be the primary causative agent in postoperative surgical site infections. The nose and nasal vestibules are a rich source of endogenous bacteria and have been linked as a primary source for infectious organisms. Nasal decolonization is an evidence-based intervention that has been shown to be effective in the reduction of healthcare associated infections (HAIs). Surgical nasal decolonization studies have demonstrated a reduction in surgical site infections (SSIs) in orthopedic and cardiothoracic surgery.
Nasal decolonization is now recognized as an important adjunct in infection control for hospitalized patients 1, 2, 3. This paper evaluated the outcomes of a 90-day trial of nasal decolonization in a long-term, acute care 40-bed hospital setting. All inpatients were offered a surgically proven, two-step nasal decolonization method once per day. The number of blood and sputum cultures sent for microbiologic evaluation, and the number of positive cultures f rom those sent, during the 90-day period were recorded.
Prevention of healthcare associated infections (HAIs) remains a priority for hospitals and healthcare facilities. Every year nearly 1.7 million hospitalized patients acquire an HAI while being treated for another health issue, and more than 98,000 patients die due to these infections.
